Will Tesla Stock Go Up In 2026?
EV giant Tesla (NASDAQ:TSLA) has, somewhat surprisingly, undershot the broader…
Sell
40
MAQAF Quote, Financials, Valuation and Earnings
Last price:
$3.24
Seasonality move
:
0.53%
Day range:
$3.24 - $3.24
52-week range:
$2.69 - $3.60
Dividend yield:
0%
P/E ratio:
30.75x
P/S ratio:
47.18x
P/B ratio:
2.44x
Volume:
--
Avg. volume:
403
1-year change:
7.1%
Market cap:
$4.7B
Revenue:
$96.2M
EPS (TTM):
$0.11
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
MAQAF
Atlas Arteria Ltd.
|
-- | -- | -- | -- | -- |
|
AUTLF
Austal Ltd.
|
-- | -- | -- | -- | -- |
|
BXBLY
Brambles Ltd.
|
-- | -- | -- | -- | -- |
|
EESH
EESTech, Inc.
|
-- | -- | -- | -- | -- |
|
GVH
Globavend Holdings Ltd.
|
-- | -- | -- | -- | $23.00 |
|
NVX
NOVONIX Ltd.
|
-- | -- | -- | -- | $3.30 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
MAQAF
Atlas Arteria Ltd.
|
$3.24 | -- | $4.7B | 30.75x | $0.13 | 0% | 47.18x |
|
AUTLF
Austal Ltd.
|
$4.17 | -- | $1.8B | 27.80x | $0.02 | 0% | 1.34x |
|
BXBLY
Brambles Ltd.
|
$30.56 | -- | $21B | 24.57x | $0.42 | 2.64% | 3.18x |
|
EESH
EESTech, Inc.
|
$0.0025 | -- | $779.5K | -- | $0.00 | 0% | 1,281.86x |
|
GVH
Globavend Holdings Ltd.
|
$3.31 | $23.00 | $607.7K | 0.58x | $0.00 | 0% | 1.75x |
|
NVX
NOVONIX Ltd.
|
$1.02 | $3.30 | $162.5M | -- | $0.00 | 0% | 24.34x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
MAQAF
Atlas Arteria Ltd.
|
35.28% | -0.201 | -- | 2.71x |
|
AUTLF
Austal Ltd.
|
20.8% | 0.161 | -- | 0.85x |
|
BXBLY
Brambles Ltd.
|
45.98% | 0.708 | -- | 0.43x |
|
EESH
EESTech, Inc.
|
-- | 61,902.132 | -- | -- |
|
GVH
Globavend Holdings Ltd.
|
-- | 4.569 | -- | 2.32x |
|
NVX
NOVONIX Ltd.
|
-- | 0.389 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
MAQAF
Atlas Arteria Ltd.
|
-- | -- | 4.21% | 5.38% | -- | -- |
|
AUTLF
Austal Ltd.
|
-- | -- | 2.25% | 2.76% | -- | -- |
|
BXBLY
Brambles Ltd.
|
-- | -- | 14.78% | 26.28% | -- | -- |
|
EESH
EESTech, Inc.
|
-- | -$201.5K | -- | -- | -- | -$93.1K |
|
GVH
Globavend Holdings Ltd.
|
-- | -- | 73.61% | 73.61% | -- | -- |
|
NVX
NOVONIX Ltd.
|
-- | -- | -- | -- | -- | -- |
Atlas Arteria Ltd. vs. Competitors
-
Which has Higher Returns MAQAF or AUTLF?
Austal Ltd. has a net margin of -- compared to Atlas Arteria Ltd.'s net margin of --. Atlas Arteria Ltd.'s return on equity of 5.38% beat Austal Ltd.'s return on equity of 2.76%.
Company Gross Margin Earnings Per Share Invested Capital MAQAFAtlas Arteria Ltd.-- -- $5.1B AUTLFAustal Ltd.-- -- $853M -
What do Analysts Say About MAQAF or AUTLF?
Atlas Arteria Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Austal Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Atlas Arteria Ltd. has higher upside potential than Austal Ltd., analysts believe Atlas Arteria Ltd. is more attractive than Austal Ltd..
Company Buy Ratings Hold Ratings Sell Ratings MAQAFAtlas Arteria Ltd.0 0 0 AUTLFAustal Ltd.0 0 0 -
Is MAQAF or AUTLF More Risky?
Atlas Arteria Ltd. has a beta of 0.539, which suggesting that the stock is 46.123% less volatile than S&P 500. In comparison Austal Ltd. has a beta of 0.885, suggesting its less volatile than the S&P 500 by 11.531%.
-
Which is a Better Dividend Stock MAQAF or AUTLF?
Atlas Arteria Ltd. has a quarterly dividend of $0.13 per share corresponding to a yield of 0%. Austal Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.02 per share. Atlas Arteria Ltd. pays 210.75% of its earnings as a dividend. Austal Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MAQAF or AUTLF?
Atlas Arteria Ltd. quarterly revenues are --, which are smaller than Austal Ltd. quarterly revenues of --. Atlas Arteria Ltd.'s net income of -- is lower than Austal Ltd.'s net income of --. Notably, Atlas Arteria Ltd.'s price-to-earnings ratio is 30.75x while Austal Ltd.'s PE ratio is 27.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Atlas Arteria Ltd. is 47.18x versus 1.34x for Austal Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MAQAFAtlas Arteria Ltd.47.18x 30.75x -- -- AUTLFAustal Ltd.1.34x 27.80x -- --
-
Which has Higher Returns MAQAF or BXBLY?
Brambles Ltd. has a net margin of -- compared to Atlas Arteria Ltd.'s net margin of --. Atlas Arteria Ltd.'s return on equity of 5.38% beat Brambles Ltd.'s return on equity of 26.28%.
Company Gross Margin Earnings Per Share Invested Capital MAQAFAtlas Arteria Ltd.-- -- $5.1B BXBLYBrambles Ltd.-- -- $5.9B -
What do Analysts Say About MAQAF or BXBLY?
Atlas Arteria Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Brambles Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Atlas Arteria Ltd. has higher upside potential than Brambles Ltd., analysts believe Atlas Arteria Ltd. is more attractive than Brambles Ltd..
Company Buy Ratings Hold Ratings Sell Ratings MAQAFAtlas Arteria Ltd.0 0 0 BXBLYBrambles Ltd.0 0 0 -
Is MAQAF or BXBLY More Risky?
Atlas Arteria Ltd. has a beta of 0.539, which suggesting that the stock is 46.123% less volatile than S&P 500. In comparison Brambles Ltd. has a beta of 0.789, suggesting its less volatile than the S&P 500 by 21.113%.
-
Which is a Better Dividend Stock MAQAF or BXBLY?
Atlas Arteria Ltd. has a quarterly dividend of $0.13 per share corresponding to a yield of 0%. Brambles Ltd. offers a yield of 2.64% to investors and pays a quarterly dividend of $0.42 per share. Atlas Arteria Ltd. pays 210.75% of its earnings as a dividend. Brambles Ltd. pays out 61.42% of its earnings as a dividend. Brambles Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Atlas Arteria Ltd.'s is not.
-
Which has Better Financial Ratios MAQAF or BXBLY?
Atlas Arteria Ltd. quarterly revenues are --, which are smaller than Brambles Ltd. quarterly revenues of --. Atlas Arteria Ltd.'s net income of -- is lower than Brambles Ltd.'s net income of --. Notably, Atlas Arteria Ltd.'s price-to-earnings ratio is 30.75x while Brambles Ltd.'s PE ratio is 24.57x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Atlas Arteria Ltd. is 47.18x versus 3.18x for Brambles Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MAQAFAtlas Arteria Ltd.47.18x 30.75x -- -- BXBLYBrambles Ltd.3.18x 24.57x -- --
-
Which has Higher Returns MAQAF or EESH?
EESTech, Inc. has a net margin of -- compared to Atlas Arteria Ltd.'s net margin of --. Atlas Arteria Ltd.'s return on equity of 5.38% beat EESTech, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MAQAFAtlas Arteria Ltd.-- -- $5.1B EESHEESTech, Inc.-- -$0.00 -- -
What do Analysts Say About MAQAF or EESH?
Atlas Arteria Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand EESTech, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Atlas Arteria Ltd. has higher upside potential than EESTech, Inc., analysts believe Atlas Arteria Ltd. is more attractive than EESTech, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MAQAFAtlas Arteria Ltd.0 0 0 EESHEESTech, Inc.0 0 0 -
Is MAQAF or EESH More Risky?
Atlas Arteria Ltd. has a beta of 0.539, which suggesting that the stock is 46.123% less volatile than S&P 500. In comparison EESTech, Inc. has a beta of 6,663.206, suggesting its more volatile than the S&P 500 by 666220.586%.
-
Which is a Better Dividend Stock MAQAF or EESH?
Atlas Arteria Ltd. has a quarterly dividend of $0.13 per share corresponding to a yield of 0%. EESTech, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Atlas Arteria Ltd. pays 210.75% of its earnings as a dividend. EESTech, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MAQAF or EESH?
Atlas Arteria Ltd. quarterly revenues are --, which are smaller than EESTech, Inc. quarterly revenues of --. Atlas Arteria Ltd.'s net income of -- is lower than EESTech, Inc.'s net income of -$201.5K. Notably, Atlas Arteria Ltd.'s price-to-earnings ratio is 30.75x while EESTech, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Atlas Arteria Ltd. is 47.18x versus 1,281.86x for EESTech, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MAQAFAtlas Arteria Ltd.47.18x 30.75x -- -- EESHEESTech, Inc.1,281.86x -- -- -$201.5K
-
Which has Higher Returns MAQAF or GVH?
Globavend Holdings Ltd. has a net margin of -- compared to Atlas Arteria Ltd.'s net margin of --. Atlas Arteria Ltd.'s return on equity of 5.38% beat Globavend Holdings Ltd.'s return on equity of 73.61%.
Company Gross Margin Earnings Per Share Invested Capital MAQAFAtlas Arteria Ltd.-- -- $5.1B GVHGlobavend Holdings Ltd.-- -- $4.4M -
What do Analysts Say About MAQAF or GVH?
Atlas Arteria Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Globavend Holdings Ltd. has an analysts' consensus of $23.00 which suggests that it could grow by 594.86%. Given that Globavend Holdings Ltd. has higher upside potential than Atlas Arteria Ltd., analysts believe Globavend Holdings Ltd. is more attractive than Atlas Arteria Ltd..
Company Buy Ratings Hold Ratings Sell Ratings MAQAFAtlas Arteria Ltd.0 0 0 GVHGlobavend Holdings Ltd.1 0 0 -
Is MAQAF or GVH More Risky?
Atlas Arteria Ltd. has a beta of 0.539, which suggesting that the stock is 46.123% less volatile than S&P 500. In comparison Globavend Holdings Ltd. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MAQAF or GVH?
Atlas Arteria Ltd. has a quarterly dividend of $0.13 per share corresponding to a yield of 0%. Globavend Holdings Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Atlas Arteria Ltd. pays 210.75% of its earnings as a dividend. Globavend Holdings Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MAQAF or GVH?
Atlas Arteria Ltd. quarterly revenues are --, which are smaller than Globavend Holdings Ltd. quarterly revenues of --. Atlas Arteria Ltd.'s net income of -- is lower than Globavend Holdings Ltd.'s net income of --. Notably, Atlas Arteria Ltd.'s price-to-earnings ratio is 30.75x while Globavend Holdings Ltd.'s PE ratio is 0.58x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Atlas Arteria Ltd. is 47.18x versus 1.75x for Globavend Holdings Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MAQAFAtlas Arteria Ltd.47.18x 30.75x -- -- GVHGlobavend Holdings Ltd.1.75x 0.58x -- --
-
Which has Higher Returns MAQAF or NVX?
NOVONIX Ltd. has a net margin of -- compared to Atlas Arteria Ltd.'s net margin of --. Atlas Arteria Ltd.'s return on equity of 5.38% beat NOVONIX Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MAQAFAtlas Arteria Ltd.-- -- $5.1B NVXNOVONIX Ltd.-- -- -- -
What do Analysts Say About MAQAF or NVX?
Atlas Arteria Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand NOVONIX Ltd. has an analysts' consensus of $3.30 which suggests that it could grow by 223.53%. Given that NOVONIX Ltd. has higher upside potential than Atlas Arteria Ltd., analysts believe NOVONIX Ltd. is more attractive than Atlas Arteria Ltd..
Company Buy Ratings Hold Ratings Sell Ratings MAQAFAtlas Arteria Ltd.0 0 0 NVXNOVONIX Ltd.1 0 0 -
Is MAQAF or NVX More Risky?
Atlas Arteria Ltd. has a beta of 0.539, which suggesting that the stock is 46.123% less volatile than S&P 500. In comparison NOVONIX Ltd. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MAQAF or NVX?
Atlas Arteria Ltd. has a quarterly dividend of $0.13 per share corresponding to a yield of 0%. NOVONIX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Atlas Arteria Ltd. pays 210.75% of its earnings as a dividend. NOVONIX Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MAQAF or NVX?
Atlas Arteria Ltd. quarterly revenues are --, which are smaller than NOVONIX Ltd. quarterly revenues of --. Atlas Arteria Ltd.'s net income of -- is lower than NOVONIX Ltd.'s net income of --. Notably, Atlas Arteria Ltd.'s price-to-earnings ratio is 30.75x while NOVONIX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Atlas Arteria Ltd. is 47.18x versus 24.34x for NOVONIX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MAQAFAtlas Arteria Ltd.47.18x 30.75x -- -- NVXNOVONIX Ltd.24.34x -- -- --
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
What Are the Best AI Power Stocks?
As the construction of AI infrastructure accelerates, the gap between…
Is IONQ The Best Quantum Stock to Buy?
Riding a wave of investor enthusiasm for the technology, quantum…
Stock Ideas
Sell
47
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 60x
Buy
58
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
73
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 39x
Alerts
Buy
80
FEIM alert for Dec 15
Frequency Electronics, Inc. [FEIM] is down 3.51% over the past day.
Buy
57
MOD alert for Dec 15
Modine Manufacturing Co. [MOD] is up 1.79% over the past day.
Sell
42
OKLO alert for Dec 15
Oklo, Inc. [OKLO] is down 5.81% over the past day.
